Efficacy of triamcinolone acetonide aerosol nasal inhaler in children with perennial allergic rhinitis

Pediatric Asthma, Allergy and Immunology

Volumn 10, Issue 2, 1996, Pages 59-64

  Storms, William W ^a   Southern, D Loren ^b   Feiss, Gary ^c   Simpson, Brandon ^c   Furst, John A ^c   Smith, Joseph A ^c  

^a Asthma & Allergy Associates PC and Research Center   (United States)

^b Princeton Allergy and Asthma Associates   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; TRIAMCINOLONE ACETONIDE;

AEROSOL; ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTITIS MEDIA; PERENNIAL RHINITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINUSITIS; SNEEZING;

EID: 0029813556     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1996.10.59     Document Type: Article

References (14)

1. Druce HM, Kaliner MA. Allergic rhinitis. JAMA 1988;259:260-263.
2. Mabry RL. Corticosteroids in the management of upper respiratory allergy: the emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg 1992;107:855-860.
3. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-869.
4. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-991.
5. Feiss G, Morris R, Rom D, et al. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. J Allergy Clin Immunol 1992;89:1151-1156.
6. Findlay S, Huber F, Garcia J, Huang L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992;68:228-232.
7. Spector S, Bronsky E, Chervinsky P, et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy 1990;64:300-305.
8. Storms W, Bronsky E, Findlay S, et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy 1991;66:329-334.
9. Tinkelman D, Falliers C, Gross G, et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann Allergy 1990;64:234-240.
10. Welch MJ, Bronsky EA, Findlay S, et al. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin Ther 1994;16:253-262.
11. Welch MJ, Bronsky EA, Grossman J, et al. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy 1991;67:493-498.
12. Banov CH, Silvers WS, Green AW, et al. A placebo-controlled, double-blind study of the efficacy of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clin Ther 1996;18:265-272.
13. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 1980;6:113-135.
14. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277.